Doxorubicin plus trabectedin for metastatic or unresectable leiomyosarcoma – Authors' reply

Patricia Pautier, Marie Laure Tanguy, Baptiste Archambaud

Résultats de recherche: Contribution à un journal › Letter › Revue par des pairs

Accès au document

@article{6c1e77fb2ab6409da6b24af6c29a2a4c,

title = "Doxorubicin plus trabectedin for metastatic or unresectable leiomyosarcoma – Authors' reply",

author = "Patricia Pautier and Tanguy, {Marie Laure} and Baptiste Archambaud",

year = "2022",

month = oct,

day = "1",

doi = "10.1016/S1470-2045(22)00563-0",

language = "English",

volume = "23",

pages = "e445",

journal = "The Lancet Oncology",

issn = "1470-2045",

number = "10",

}

TY - JOUR

T1 - Doxorubicin plus trabectedin for metastatic or unresectable leiomyosarcoma – Authors' reply

AU - Pautier, Patricia

AU - Tanguy, Marie Laure

AU - Archambaud, Baptiste

PY - 2022/10/1

Y1 - 2022/10/1

UR - http://www.scopus.com/inward/record.url?scp=85138768465&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(22)00563-0

DO - 10.1016/S1470-2045(22)00563-0

M3 - Letter

C2 - 36174626

AN - SCOPUS:85138768465

SN - 1470-2045

VL - 23

SP - e445

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 10

ER -